Initial Experience With Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors (NETS) at a Tertiary Care United States Center

被引：0
作者：
Heckert, Jason [1 ]
Botterbusch, Samuel [2 ]
Kipnis, Sarit [1 ]
Bennet, Bonita [3 ]
Creamer, Caroline [3 ]
Alderson, Alice [3 ]
Eads, Jennifer [3 ]
Soulen, Michael [3 ]
Pryma, Daniel [3 ]
Mankoff, David [3 ]
Metz, David [3 ]
Katona, Bryson [3 ]
机构：
[1] Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] Perelman Sch Med, Philadelphia, PA USA
来源：
PANCREAS | 2020年 / 49卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：470 / 471
页数：2
相关论文
共 50 条
  • [31] TUMOR RESPONSE TO PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) IN A UNITED STATES-BASED NEUROENDOCRINE TUMOR COHORT
    Kipnis, Sarit T.
    Hung, Matthew
    Heckert, Jason
    Bennett, Bonita J.
    Creamer, Caroline
    Eads, Jennifer
    Soulen, Michael C.
    Pryma, Daniel
    Mankoff, David
    Metz, David C.
    Katona, Bryson W.
    GASTROENTEROLOGY, 2020, 158 (06) : S292 - S292
  • [32] Chronic Complications of Peptide Receptor Radionuclide Therapy (PRRT) - A Single Center Experience
    Fraenkel, M.
    Barak, D.
    Mueller-Brand, J.
    Krausz, Y.
    Glaser, B.
    Salmon, A.
    Gross, D. J.
    NEUROENDOCRINOLOGY, 2010, 92 (01) : 30 - 30
  • [33] The role of systemic inflammatory factors in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with peptide receptor radionuclide therapy (PRRT).
    Abou Jokh Casas, Estephany
    Lago, Nieves Martinez
    Cabezas Agricola, Jose Manuel
    Herranz, Urbano Anido
    Baron, Francisco
    Calvo, Ovidio Fernandez
    Varela, Maria Quindos
    Ferreiro, Silvia Varela
    Maseda, Alberto Carral
    De Matias Leralta, Jose Maria
    Seoane, Zulema Nogareda
    Castineira, Antia Cousillas
    Martinez de LLano, Sofia Rodriguez
    Mato Mato, Jose Antonio
    Catalina, Pablo Fernandez
    Fonseca, Omar Rodriguez
    Garcia, Gloria Muniz
    Bernardez, Beatriz
    Cameselle Teijeiro, Jose Manuel
    Nunez, Virginia Pubul
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [34] Real-world efficacy and safety of peptide receptor radionuclide therapy (PRRT) in gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
    Abou Jokh Casas, Estephany
    Martinez, Nieves Purificacion
    Herranz, Urbano Anido
    Cabezas Agricola, Jose Manuel
    Ferreiro, Silvia Varela
    Maseda, Alberto Carral
    Calvo, Ovidio Fernandez
    Mato Mato, Jose Antonio
    Seoane, Zulema Nogareda
    Martinez de LLano, Sofia Rodriguez
    Varela, Maria Quindos
    Baron, Francisco
    Fonseca, Omar Rodriguez
    Castineira, Antia Cousillas
    Garcia, Gloria Muniz
    De Matias Leralta, Jose Maria
    Catalina, Pablo Fernandez
    Cameselle Teijeiro, Jose Manuel
    Bernardez, Beatriz
    Nunez, Virginia Pubul
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [35] Immediate Adverse Effects of Peptide Receptor Radionuclide Therapy (PRRT) Administration in Patients with Neuroendocrine Tumors (NETs): A Single Institution Review
    Wee, C.
    Dundar, A.
    Packard, A.
    Kendi, A. T.
    Eiring, R.
    Hobday, T.
    Halfdanarson, T.
    NEUROENDOCRINOLOGY, 2020, 110 : 277 - 277
  • [36] Hepatotoxicity From Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NETs) Patients With Very High Liver Tumor Burden
    Gococo-Benore, Denise A.
    Parent, Ephraim
    Sharma, Akash
    Accurso, Joseph
    Yang, Ming
    Kendi, Ayse Tuba
    Sonbol, Bassam
    Halfdanarson, Thorvardur R.
    Starr, Jason S.
    PANCREAS, 2022, 51 (03) : E47 - E47
  • [37] Treatment of Gastroenteropancreatic Neuroendocrine Tumors with Peptide Receptor Radionuclide Therapy
    van Vliet, Esther I.
    Teunissen, Jaap J. M.
    Kam, Boen L. R.
    de Jong, Marion
    Krenning, Eric P.
    Kwekkeboom, Dik J.
    NEUROENDOCRINOLOGY, 2013, 97 (01) : 74 - 85
  • [38] Efficacy and tolerability of peptide receptor radionuclide therapy (PRRT) in advanced metastatic bronchial neuroendocrine tumours (NETs)
    Mirvis, Eitan
    Toumpanakis, Christos
    Mandair, Dalvinder
    Gnanasegaran, Gopinath
    Caplin, Martyn
    Navalkissoor, Shaunak
    LUNG CANCER, 2020, 150 : 70 - 75
  • [39] The value of dosimetry in Peptide Receptor Radionuclide Therapy (PRRT) for neuroendocrine tumors: literature and practical aspects
    Di Dia, Amalia
    Ferrari, Mahila E.
    Travaini, Laura Lavinia
    Grappeja, Lorenza
    Guglielmo, Priscilla
    Barone, Antonio
    Mei, Riccardo
    Papi, Stefano
    Ceci, Francesco
    Grana, Chiara Maria
    CLINICAL AND TRANSLATIONAL IMAGING, 2025, : 121 - 129
  • [40] Peptide Receptor Radionuclide Therapy (PRRT) in Patients with Metastatic Neuroendocrine Tumors: How Effective and Safe Are They?
    Liotsou, T.
    Stefanoyiannis, A. P.
    Chatziioannou, S. N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S725 - S726
12345